Predictive Oncology (POAI) Stock Statistics & Valuation Metrics

Predictive Oncology has a market cap or net worth of $8.72M. The enterprise value is $8.48M.

Predictive Oncology has 8,931,621 shares outstanding. The number of shares has decreased by -2.65% in one year.

Predictive Oncology’s return on equity (ROE) is 60.22 and return on invested capital (ROIC) is -433.32%.

The current PE Ratio of Predictive Oncology is -0.37. Predictive Oncology’s PEG ratio is -0.03.

In the last 12 months, Predictive Oncology had revenue of 1.62M and earned -12.20M in profits. Earnings per share was -2.32.

In the last 12 months, operating cash flow was -8.54M and capital expenditures -6.48K, giving a free cash flow of -8.55M billion.

Predictive Oncology pays an annual dividend of ―, resulting in a dividend yield of ―

Predictive Oncology upcoming earnings date is Aug 7, 2025, TBA Not Confirmed.

Predictive Oncology as a current ratio of 0.62, with Debt / Equity ratio of -1315.73%

In the past 12 months, Predictive Oncology has paid 0.00 in taxes.

Predictive Oncology EV to EBITDA ratio is -0.58, with an EV/FCF ratio of -0.53.

Predictive Oncology has $3.09M in cash and marketable securities with $1.92M in debt, giving a net cash position of -$1.17M billion.

Gross margin is 36.88%, with operating margin of -673.69%, and net profit margin of -751.39%.

The average price target for Predictive Oncology is ―, which is 11.43% higher than the current price. The consensus rating is Hold